Phio Pharmaceuticals Corp. (PHIO)
1.14
+0.04
(+3.64%)
USD |
NASDAQ |
Sep 02, 16:00
1.14
0.00 (0.00%)
After-Hours: 20:00
Phio Pharmaceuticals Cash from Operations (TTM) : -12.20M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.20M |
| March 31, 2026 | -10.71M |
| December 31, 2025 | -7.979M |
| September 30, 2025 | -7.271M |
| June 30, 2025 | -7.139M |
| March 31, 2025 | -6.376M |
| December 31, 2024 | -7.112M |
| September 30, 2024 | -8.111M |
| June 30, 2024 | -9.058M |
| March 31, 2024 | -10.05M |
| December 31, 2023 | -10.75M |
| September 30, 2023 | -11.08M |
| June 30, 2023 | -11.71M |
| March 31, 2023 | -11.37M |
| December 31, 2022 | -12.13M |
| September 30, 2022 | -11.90M |
| June 30, 2022 | -11.47M |
| March 31, 2022 | -12.29M |
| December 31, 2021 | -11.86M |
| September 30, 2021 | -12.01M |
| June 30, 2021 | -10.88M |
| March 31, 2021 | -9.659M |
| December 31, 2020 | -8.802M |
| September 30, 2020 | -8.725M |
| June 30, 2020 | -8.745M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.646M |
| December 31, 2019 | -8.645M |
| September 30, 2019 | -7.845M |
| June 30, 2019 | -7.861M |
| March 31, 2019 | -7.788M |
| December 31, 2018 | -7.52M |
| September 30, 2018 | -7.975M |
| June 30, 2018 | -8.165M |
| March 31, 2018 | -8.622M |
| December 31, 2017 | -9.514M |
| September 30, 2017 | -8.685M |
| June 30, 2017 | -8.091M |
| March 31, 2017 | -7.634M |
| December 31, 2016 | -7.76M |
| September 30, 2016 | -7.97M |
| June 30, 2016 | -8.33M |
| March 31, 2016 | -8.27M |
| December 31, 2015 | -7.317M |
| September 30, 2015 | -7.33M |
| June 30, 2015 | -7.133M |
| March 31, 2015 | -7.35M |
| December 31, 2014 | -7.758M |
| September 30, 2014 | -7.565M |
| June 30, 2014 | -7.524M |
| March 31, 2014 | -7.563M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Imunon, Inc. | -15.11M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 12.48B |
| Anika Therapeutics, Inc. | 5.977M |
| BioCryst Pharmaceuticals, Inc. | 358.99M |